South San Francisco, CA September 13, 2018 Submitted by Daniel Morris Genentech’s coed team came in 2nd place in the championship game on the Archie Fregosi field at Orange Memorial Park on Monday. It was a great battle between the…
Tag: Genentech
Genentech to Present New Data from Its Extensive Lung Cancer Program at the 2018 World Conference on Lung Cancer
South San Francisco, CA September 5, 2018 Press Release Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced that new data from its broad clinical development program across different types of lung cancer will be…
Genentech’s HEMLIBRA® Offers Promise to Hemophilia Patients
South San Francisco, CA August 30, 2018 Press Release Positive Phase III Results for Genentech’s HEMLIBRA® (emicizumab-kxwh) for Hemophilia A Without Factor VIII Inhibitors Published in New England Journal of Medicine — HEMLIBRA prophylaxis significantly reduced bleeds compared to no…
Genentech Unveils Positive Phase II Results for the First-Ever Eye Implant
South San Francisco, CA July 24, 2018 Press Release Genentech Unveils Positive Phase II Results for the First-Ever Eye Implant to Achieve Sustained Delivery of a Biologic Medicine to Treat People With Wet Age-Related Macular Degeneration (AMD) Genentech’s investigational Port…
Study Results from Genentech’s Baloxavir Marboxil and Influenza
South San Francisco, CA July 17, 2018 Press Release Phase III CAPSTONE-2 Study Showed That Baloxavir Marboxil Reduced Symptoms in People at High Risk of Complications From the Flu — Baloxavir marboxil – an investigational oral, single-dose antiviral – is…
Genentech’s TECENTRIQ in Combination with Chemotherapy Helps Patients With Small Cell Lung Cancer
South San Francisco, CA June 30, 2018 Press Release Genentech’s TECENTRIQ in Combination with Chemotherapy Helped People with Previously-Untreated Extensive-Stage Small Cell Lung Cancer Live Significantly Longer Compared to Chemotherapy –IMpower133 is the first Phase III study with an immunotherapy-based…
FDA Grants Priority Review to Genentech’s Baloxavir Marboxil for the Treatment of Influenza
South San Francisco, CA June 26, 2018 Genentech Press Release — Influenza, or “flu,” represents a serious threat to public health – globally, annual epidemics result in 3 to 5 million cases of severe disease, millions of hospitalizations and up…
County of San Mateo Wins Property Tax Lawsuit Against Genentech
South San Francisco, CA June 19, 2018 Submitted by San Mateo County The County of San Mateo has preserved approximately $9.5 million in property tax revenues for residents in a successful lawsuit against Genentech, Inc. The Superior Court ruled that…
South San Francisco Unified School District to Present Updates to City Council Wednesday June 13th 7pm
South San Francisco, Ca June 11, 2018 The public is invited to attend the special meeting on Wednesday June 13th at 7:01pm in the City Council Chambers, 33 Arroyo Drive SSF, as the School District presents updates on campus projects…
Scholarship America Presents Honors Genentech FuturelabProgram
South San Francisco, Ca May 24, 2018 Submitted by KM, originated Longview News Journal Preface: A South City neighbor sent us this article saying ‘My daughter was part of the Genentech FutureLab Program and it really helped her to focus…